Five things for pharma marketers to know: Thursday, August 31, 2017
1. Pfizer is using video games to help kids with hemophilia learn more about their disorder. The drugmaker launched a modification of the popular video game Minecraft to educate patients about how to stick to a treatment plan. (MobiHealthNews)
2. The FDA invited Eli Lilly and Incyte to resubmit an application for their experimental rheumatoid arthritis drug, baricitinib, without completing a new clinical trial. The FDA had rejected the drug's application in April and requested more data. (Endpoints News)
3. Dr. Peter Bach, director of Memorial Sloan Kettering Cancer Center's Drug Pricing Lab, wrote in an op-ed that Novartis' value-based contract with the Centers for Medicare and Medicaid Services for its new CAR-T drug Kymriah is a “step forward toward value-pricing.” He noted that the “few outcomes-based contracts that have been announced in the past have generally been between private insurers and pharmaceutical companies, and the terms have been proprietary.” (Stat)
4. People who live in Hawaii are less likely to use prescription drugs like opioids and antibiotics compared to those living in the continental U.S. (NPR)
5. Dr. Richard Moscicki, former deputy director for science operations at the FDA's Center for Drug Evaluation and Research, has joined PhRMA as its new chief medical officer.